The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors.

Methods in molecular biology (Clifton, N.J.)

Volumn 506, Issue , 2009, Pages 477-488

  Wilson, Carolyn A ^a   Cichutek, Klaus ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CYTOLOGY; EUROPEAN UNION; GENE VECTOR; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; JURISPRUDENCE; METABOLISM; RETROVIRUS; UNITED STATES;

EUROPEAN UNION; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; JURISPRUDENCE; RETROVIRIDAE; UNITED STATES;

EID: 60749130345     PISSN: 10643745     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-59745-409-4_32     Document Type: Article

References (0)